{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:52:30Z","timestamp":1773089550515,"version":"3.50.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41431-018-0104-8","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T13:33:58Z","timestamp":1519392838000},"page":"765-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Genetic predictors of systemic sclerosis-associated interstitial lung disease: a review of recent literature"],"prefix":"10.1038","volume":"26","author":[{"given":"Carmel J. W.","family":"Stock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta A.","family":"Renzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"104_CR1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","volume":"176","author":"H Schurawitzki","year":"1990","unstructured":"Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology. 1990;176:755\u20139.","journal-title":"Radiology"},{"key":"104_CR2","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/art.1780370903","volume":"37","author":"VD Steen","year":"1994","unstructured":"Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum. 1994;37:1283\u20139.","journal-title":"Arthritis Rheum"},{"key":"104_CR3","first-page":"81","volume":"24","author":"S Morelli","year":"1997","unstructured":"Morelli S, Barbieri C, Sgreccia A, et al. Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol. 1997;24:81\u20135.","journal-title":"J Rheumatol"},{"key":"104_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/sj.gene.6363734","volume":"2","author":"FC Gilchrist","year":"2001","unstructured":"Gilchrist FC, Bunn C, Foley PJ, et al. Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun. 2001;2:76\u201381.","journal-title":"Genes Immun"},{"key":"104_CR5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1164\/rccm.2106012","volume":"165","author":"D Bouros","year":"2002","unstructured":"Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002;165:1581\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"104_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med. 2008;177:1248\u201354.","journal-title":"Am J Respir Crit Care Med"},{"key":"104_CR7","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","volume":"44","author":"FC Arnett","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001;44:1359\u201362.","journal-title":"Arthritis Rheum"},{"key":"104_CR8","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246\u201355.","journal-title":"Arthritis Rheum"},{"key":"104_CR9","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/art.1780390814","volume":"39","author":"FC Arnett","year":"1996","unstructured":"Arnett FC, Howard RF, Tan F, et al. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum. 1996;39:1362\u201370.","journal-title":"Arthritis Rheum"},{"key":"104_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y","volume":"42","author":"M Kuwana","year":"1999","unstructured":"Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum. 1999;42:465\u201374.","journal-title":"Arthritis Rheum"},{"key":"104_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","volume":"42","author":"R Hesselstrand","year":"2003","unstructured":"Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology. 2003;42:534\u201340.","journal-title":"Rheumatology"},{"key":"104_CR12","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr., Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48:1956\u201363.","journal-title":"Arthritis Rheum"},{"key":"104_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.autrev.2016.01.016","volume":"15","author":"G Murdaca","year":"2016","unstructured":"Murdaca G, Contatore M, Gulli R, Mandich P, Puppo F. Genetic factors and systemic sclerosis. Autoimmun Rev. 2016;15:427\u201332.","journal-title":"Autoimmun Rev"},{"key":"104_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.humimm.2016.10.017","volume":"78","author":"P Chairta","year":"2017","unstructured":"Chairta P, Nicolaou P, Christodoulou K. Genomic and genetic studies of systemic sclerosis: a systematic review. Hum Immunol. 2017;78:153\u201365.","journal-title":"Hum Immunol"},{"key":"104_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/BOR.0000000000000214","volume":"27","author":"PS Ramos","year":"2015","unstructured":"Ramos PS, Silver RM, Feghali-Bostwick CA. Genetics of systemic sclerosis: recent advances. Curr Opin Rheumatol. 2015;27:521\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"104_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/rheumatology\/37.2.201","volume":"37","author":"GC Fanning","year":"1998","unstructured":"Fanning GC, Welsh KI, Bunn C, Du BR, Black CM. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol. 1998;37:201\u20137.","journal-title":"Br J Rheumatol"},{"key":"104_CR17","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3899\/jrheum.090377","volume":"36","author":"CP Simeon","year":"2009","unstructured":"Simeon CP, Fonollosa V, Tolosa C, et al. Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol. 2009;36:2733\u20136.","journal-title":"J Rheumatol"},{"key":"104_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.0001-2815.2004.00199.x","volume":"63","author":"M Tikly","year":"2004","unstructured":"Tikly M, Rands A, McHugh N, Wordsworth P, Welsh K. Human leukocyte antigen class II associations with systemic sclerosis in South Africans. Tissue Antigens. 2004;63:487\u201390.","journal-title":"Tissue Antigens"},{"key":"104_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/rheumatology\/kes149","volume":"51","author":"T Odani","year":"2012","unstructured":"Odani T, Yasuda S, Ota Y, et al. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. Rheumatology. 2012;51:1765\u201374.","journal-title":"Rheumatology"},{"key":"104_CR20","doi-asserted-by":"publisher","first-page":"e87363","DOI":"10.1371\/journal.pone.0087363","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Guo X, Yi L, et al. Association of HLA-DPB1 with scleroderma and its clinical features in Chinese population. PLoS ONE. 2014;9:e87363.","journal-title":"PLoS ONE"},{"key":"104_CR21","doi-asserted-by":"publisher","first-page":"e106939","DOI":"10.1371\/journal.pone.0106939","volume":"9","author":"D He","year":"2014","unstructured":"He D, Wang J, Yi L, et al. Association of the HLA-DRB1 with scleroderma in Chinese population. PLoS ONE. 2014;9:e106939.","journal-title":"PLoS ONE"},{"key":"104_CR22","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/art.11220","volume":"48","author":"X Zhou","year":"2003","unstructured":"Zhou X, Tan FK, Wang N, et al. Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum. 2003;48:2585\u201392.","journal-title":"Arthritis Rheum"},{"key":"104_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ng.565","volume":"42","author":"TR Radstake","year":"2010","unstructured":"Radstake TR, Gorlova O, Rueda B, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010;42:426\u20139.","journal-title":"Nat Genet"},{"key":"104_CR24","doi-asserted-by":"publisher","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","volume":"7","author":"Y Allanore","year":"2011","unstructured":"Allanore Y, Saad M, Dieude P, et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet. 2011;7:e1002091.","journal-title":"PLoS Genet"},{"key":"104_CR25","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/art.24982","volume":"60","author":"X Zhou","year":"2009","unstructured":"Zhou X, Lee JE, Arnett FC, et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum. 2009;60:3807\u201314.","journal-title":"Arthritis Rheum"},{"key":"104_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","volume":"94","author":"MD Mayes","year":"2014","unstructured":"Mayes MD, Bossini-Castillo L, Gorlova O, et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014;94:47\u201361.","journal-title":"Am J Hum Genet"},{"key":"104_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s13075-014-0438-8","volume":"16","author":"J Zochling","year":"2014","unstructured":"Zochling J, Newell F, Charlesworth JC, et al. An Immunochip based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Res Ther. 2014;16:438.","journal-title":"Arthritis Res Ther"},{"key":"104_CR28","doi-asserted-by":"publisher","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","volume":"7","author":"O Gorlova","year":"2011","unstructured":"Gorlova O, Martin JE, Rueda B, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011;7:e1002178.","journal-title":"PLoS Genet"},{"key":"104_CR29","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1073\/pnas.0611559104","volume":"104","author":"H Yanai","year":"2007","unstructured":"Yanai H, Chen HM, Inuzuka T, et al. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci USA. 2007;104:3402\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"104_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/art.24183","volume":"60","author":"P Dieude","year":"2009","unstructured":"Dieude P, Guedj M, Wipff J, et al. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum. 2009;60:225\u201333.","journal-title":"Arthritis Rheum"},{"key":"104_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/039463201402700420","volume":"27","author":"J Wang","year":"2014","unstructured":"Wang J, Yi L, Guo X, et al. Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese. Int J Immunopathol Pharmacol. 2014;27:635\u20138.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"104_CR32","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3899\/jrheum.091163","volume":"37","author":"P Dieude","year":"2010","unstructured":"Dieude P, Dawidowicz K, Guedj M, et al. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. J Rheumatol. 2010;37:987\u201392.","journal-title":"J Rheumatol"},{"key":"104_CR33","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1136\/annrheumdis-2011-200901","volume":"71","author":"R Sharif","year":"2012","unstructured":"Sharif R, Mayes MD, Tan FK, et al. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Ann Rheum Dis. 2012;71:1197\u2013202.","journal-title":"Ann Rheum Dis"},{"key":"104_CR34","doi-asserted-by":"publisher","first-page":"e54419","DOI":"10.1371\/journal.pone.0054419","volume":"8","author":"FD Carmona","year":"2013","unstructured":"Carmona FD, Martin JE, Beretta L, et al. The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis. PLoS ONE. 2013;8:e54419.","journal-title":"PLoS ONE"},{"key":"104_CR35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJMoa073003","volume":"357","author":"EF Remmers","year":"2007","unstructured":"Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357:977\u201386.","journal-title":"N Engl J Med"},{"key":"104_CR36","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1002\/art.24688","volume":"60","author":"P Dieude","year":"2009","unstructured":"Dieude P, Guedj M, Wipff J, et al. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Arthritis Rheum. 2009;60:2472\u20139.","journal-title":"Arthritis Rheum"},{"key":"104_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/039463201302600220","volume":"26","author":"L Yi","year":"2013","unstructured":"Yi L, Wang JC, Guo XJ, et al. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population. Int J Immunopathol Pharmacol. 2013;26:473\u20138.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"104_CR38","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","volume":"18","author":"B Rueda","year":"2009","unstructured":"Rueda B, Broen J, Simeon C, et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet. 2009;18:2071\u20137.","journal-title":"Hum Mol Genet"},{"key":"104_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/gene.2008.82","volume":"10","author":"JP Hafler","year":"2009","unstructured":"Hafler JP, Maier LM, Cooper JD, et al. CD226 Gly307Ser association with multiple autoimmune diseases. Genes Immun. 2009;10:5\u201310.","journal-title":"Genes Immun"},{"key":"104_CR40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/art.30204","volume":"63","author":"P Dieude","year":"2011","unstructured":"Dieude P, Guedj M, Truchetet ME, et al. Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis. Arthritis Rheum. 2011;63:1097\u2013105.","journal-title":"Arthritis Rheum"},{"key":"104_CR41","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1002\/art.27677","volume":"62","author":"SE Lofgren","year":"2010","unstructured":"Lofgren SE, Delgado-Vega AM, Gallant CJ, et al. A 3\u2019-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2010;62:3404\u201314.","journal-title":"Arthritis Rheum"},{"key":"104_CR42","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/ar3809","volume":"14","author":"L Bossini-Castillo","year":"2012","unstructured":"Bossini-Castillo L, Simeon CP, Beretta L, et al. A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis. Arthritis Res Ther. 2012;14:R85.","journal-title":"Arthritis Res Ther"},{"key":"104_CR43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/ard.2010.131243","volume":"70","author":"P Dieude","year":"2011","unstructured":"Dieude P, Guedj M, Wipff J, et al. NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis. Ann Rheum Dis. 2011;70:668\u201374.","journal-title":"Ann Rheum Dis"},{"key":"104_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2010.02.001","volume":"35","author":"RK Arora-Singh","year":"2010","unstructured":"Arora-Singh RK, Assassi S, del Junco DJ, et al. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun. 2010;35:52\u20137.","journal-title":"J Autoimmun"},{"key":"104_CR45","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.4049\/jimmunol.179.6.4125","volume":"179","author":"G Liu","year":"2007","unstructured":"Liu G, Tsuruta Y, Gao Z, Park YJ, Abraham E. Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. J Immunol. 2007;179:4125\u201334.","journal-title":"J Immunol"},{"key":"104_CR46","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1002\/art.30640","volume":"63","author":"P Dieude","year":"2011","unstructured":"Dieude P, Bouaziz M, Guedj M, et al. Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe\/532Ser haplotype. Arthritis Rheum. 2011;63:3979\u201387.","journal-title":"Arthritis Rheum"},{"key":"104_CR47","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","volume":"72","author":"FD Carmona","year":"2013","unstructured":"Carmona FD, Cenit MC, Diaz-Gallo LM, et al. New insight on the Xq28 association with systemic sclerosis. Ann Rheum Dis. 2013;72:2032\u20138.","journal-title":"Ann Rheum Dis"},{"key":"104_CR48","first-page":"149","volume":"27","author":"S Sato","year":"2000","unstructured":"Sato S, Nagaoka T, Hasegawa M, et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol. 2000;27:149\u201354.","journal-title":"J Rheumatol"},{"key":"104_CR49","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1056\/NEJMoa067655","volume":"357","author":"C Fonseca","year":"2007","unstructured":"Fonseca C, Lindahl GE, Ponticos M, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med. 2007;357:1210\u201320.","journal-title":"N Engl J Med"},{"key":"104_CR50","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1136\/ard.2008.100586","volume":"68","author":"Y Kawaguchi","year":"2009","unstructured":"Kawaguchi Y, Ota Y, Kawamoto M, et al. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis. 2009;68:1921\u20134.","journal-title":"Ann Rheum Dis"},{"key":"104_CR51","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1136\/ard.2008.100180","volume":"68","author":"B Rueda","year":"2009","unstructured":"Rueda B, Simeon C, Hesselstrand R, et al. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis. 2009;68:1618\u201320.","journal-title":"Ann Rheum Dis"},{"key":"104_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874312901105010059","volume":"5","author":"W Louthrenoo","year":"2011","unstructured":"Louthrenoo W, Kasitanon N, Wichainun R, et al. Lack of CTGF*-945C\/G dimorphism in Thai Patients with systemic sclerosis. Open Rheumatol J. 2011;5:59\u201363.","journal-title":"Open Rheumatol J"},{"key":"104_CR53","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1136\/ard.2010.147009","volume":"70","author":"P Dieude","year":"2011","unstructured":"Dieude P, Boileau C, Guedj M, et al. Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor. Ann Rheum Dis. 2011;70:1695\u20136.","journal-title":"Ann Rheum Dis"},{"key":"104_CR54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1874312901408010043","volume":"8","author":"J Wang","year":"2014","unstructured":"Wang J, Yi L, Guo X, et al. Lack of association of the CD247 SNP rs2056626 with systemic sclerosis in Han Chinese. Open Rheumatol J. 2014;8:43\u201345.","journal-title":"Open Rheumatol J"},{"key":"104_CR55","unstructured":"Genome Research in African American Scleroderma Patients \n                    http:\/\/www.srfcure.org\/research\/featured-research\n                    \n                   2018 The Scleroderma Research Foundation."},{"key":"104_CR56","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.40130","volume":"69","author":"NS Goh","year":"2017","unstructured":"Goh NS, Hoyles RK, Denton CP, et al. Short term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol. 2017;69:1670\u201378.","journal-title":"Arthritis Rheumatol"},{"key":"104_CR57","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/art.38702","volume":"66","author":"EL Herzog","year":"2014","unstructured":"Herzog EL, Mathur A, Tager AM, Feghali-Bostwick C, Schneider F, Varga J. Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct? Arthritis Rheumatol. 2014;66:1967\u201378.","journal-title":"Arthritis Rheumatol"},{"key":"104_CR58","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1148\/radiol.2322031223","volume":"232","author":"SR Desai","year":"2004","unstructured":"Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004;232:560\u20137.","journal-title":"Radiology"},{"key":"104_CR59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/thx.52.3.265","volume":"52","author":"TY Chan","year":"1997","unstructured":"Chan TY, Hansell DM, Rubens MB, du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans. Thorax. 1997;52:265\u201370.","journal-title":"Thorax"},{"key":"104_CR60","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13075-016-0923-3","volume":"18","author":"M Wu","year":"2016","unstructured":"Wu M, Assassi S, Salazar GA, et al. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis Res Ther. 2016;18:20.","journal-title":"Arthritis Res Ther"},{"key":"104_CR61","doi-asserted-by":"publisher","first-page":"e70621","DOI":"10.1371\/journal.pone.0070621","volume":"8","author":"R Borie","year":"2013","unstructured":"Borie R, Crestani B, Dieude P, et al. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS ONE. 2013;8:e70621.","journal-title":"PLoS ONE"},{"key":"104_CR62","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/thoraxjnl-2012-201786","volume":"68","author":"CJ Stock","year":"2013","unstructured":"Stock CJ, Sato H, Fonseca C, et al. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax. 2013;68:436\u201341.","journal-title":"Thorax"},{"key":"104_CR63","first-page":"1481","volume":"32","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P. HLA markers for susceptibility and expression in scleroderma. J Rheumatol. 2005;32:1481\u20137.","journal-title":"J Rheumatol"},{"key":"104_CR64","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/039463201302600318","volume":"26","author":"XD Zhou","year":"2013","unstructured":"Zhou XD, Yi L, Guo XJ, et al. Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population. Int J Immunopathol Pharmacol. 2013;26:747\u201351.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"104_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0140-6736(91)91235-M","volume":"338","author":"DC Briggs","year":"1991","unstructured":"Briggs DC, Vaughan RW, Welsh KI, Myers A, duBois RM, Black CM. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet. 1991;338:661\u20132.","journal-title":"Lancet"},{"key":"104_CR66","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00296-017-3722-5","volume":"37","author":"W Zhao","year":"2017","unstructured":"Zhao W, Yue X, Liu K, et al. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms. Rheumatol Int. 2017;37:1303\u201310.","journal-title":"Rheumatol Int"},{"key":"104_CR67","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/rheumatology\/kew499","volume":"56","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Chwiesko-Minarowska S, Bernatowicz PL, et al. The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study. Rheumatology. 2017;56:844\u201352.","journal-title":"Rheumatology"},{"key":"104_CR68","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1002\/art.30415","volume":"63","author":"K Hoshino","year":"2011","unstructured":"Hoshino K, Satoh T, Kawaguchi Y, Kuwana M. Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis. Arthritis Rheum. 2011;63:2465\u201372.","journal-title":"Arthritis Rheum"},{"key":"104_CR69","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/art.10736","volume":"48","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi Y, Tochimoto A, Ichikawa N, et al. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum. 2003;48:186\u201392.","journal-title":"Arthritis Rheum"},{"key":"104_CR70","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.humimm.2007.03.005","volume":"68","author":"L Beretta","year":"2007","unstructured":"Beretta L, Bertolotti F, Cappiello F, et al. Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology. Hum Immunol. 2007;68:603\u20139.","journal-title":"Hum Immunol"},{"key":"104_CR71","doi-asserted-by":"publisher","first-page":"gmr15049077","DOI":"10.4238\/gmr15049077","volume":"15","author":"TF Rech","year":"2016","unstructured":"Rech TF, Moraes SB, Bredemeier M et al. Matrix metalloproteinase gene polymorphisms and susceptibility to systemic sclerosis. Genet Mol Res. 2016;15:gmr15049077.","journal-title":"Genet Mol Res"},{"key":"104_CR72","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3899\/jrheum.100237","volume":"37","author":"M Manetti","year":"2010","unstructured":"Manetti M, Ibba-Manneschi L, Fatini C, et al. Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. J Rheumatol. 2010;37:1852\u20137.","journal-title":"J Rheumatol"},{"key":"104_CR73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/rheumatology\/kem355","volume":"47","author":"Y Sumita","year":"2008","unstructured":"Sumita Y, Sugiura T, Kawaguchi Y, et al. Genetic polymorphisms in the surfactant proteins in systemic sclerosis in Japanese: T\/T genotype at 1580 C\/T (Thr131Ile) in the SP-B gene reduces the risk of interstitial lung disease. Rheumatology. 2008;47:289\u201391.","journal-title":"Rheumatology"},{"key":"104_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-007-9134-7","volume":"28","author":"O Ates","year":"2008","unstructured":"Ates O, Musellim B, Ongen G, Topal-Sarikaya A. NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement. J Clin Immunol. 2008;28:73\u20137.","journal-title":"J Clin Immunol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0104-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-018-0104-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:42:02Z","timestamp":1684618922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-018-0104-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1038\/s41431-018-0104-8","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"11 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}